Alex Boye, James Asenso, Philippa Jennifer Ayiku, Wisdom Xoese Kwadzo Agroh
{"title":"Medication Errors: An Update From the Central Region of Ghana","authors":"Alex Boye, James Asenso, Philippa Jennifer Ayiku, Wisdom Xoese Kwadzo Agroh","doi":"10.1155/2024/3444425","DOIUrl":null,"url":null,"abstract":"<div>\n <p><b>Objective:</b> The study assessed the following medication error indicators: drug education by pharmacists, the clarity of physician prescription forms, patients’ and students’ drug package insert (PI) reading habits, and the adequacy of information on drug PIs.</p>\n <p><b>Design:</b> A cross-sectional study was carried out. One-on-one interviews were conducted with the pharmacists alongside the use of structured questionnaires to assess their involvement in drug education and experience with the clarity of physician prescription forms. A structured questionnaire was used to investigate patients’ and students’ PI reading habits. Drug PIs were collected from pharmacies, and their components were examined based on the World Health Organization’s (WHO) criteria for labeling pharmaceutical products.</p>\n <p><b>Setting:</b> The study was conducted at four selected hospital pharmacies, four community pharmacies, and the University of Cape Coast, in the Cape Coast Metropolis, Ghana.</p>\n <p><b>Participants:</b> The study included pharmacists working at the pharmacies, patients, and students of the University of Cape Coast, who visited any of these pharmacies.</p>\n <p><b>Results:</b> Fifty-three percent of pharmacists educate their patients on drug dosage, storage, and precautions during each patient visit, 17.6% hardly do, and 29.4% do not educate their patients. A majority of the sampled prescription forms submitted by patients to the pharmacists had illegible handwriting (63.7%) and unconventional prescription notations (78.0%). Of the 138 visiting patients, only a few (41.0%) read the PIs before drug use as compared to students (72.9%). Out of the 88 PIs collected, 90.2% had component deficiencies.</p>\n <p><b>Conclusion:</b> Pharmacists’ drug education to visiting patients was poor, just as patients’ PI reading habits. Most PIs had component deficiencies, and the majority of prescription forms had some medication error-provoking features. Going forward, pharmacists, physicians, drug manufacturers, and patients must perform their responsibilities toward the collective effort of minimizing medication errors associated with drug use.</p>\n </div>","PeriodicalId":15381,"journal":{"name":"Journal of Clinical Pharmacy and Therapeutics","volume":"2024 1","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/3444425","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Pharmacy and Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/2024/3444425","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The study assessed the following medication error indicators: drug education by pharmacists, the clarity of physician prescription forms, patients’ and students’ drug package insert (PI) reading habits, and the adequacy of information on drug PIs.
Design: A cross-sectional study was carried out. One-on-one interviews were conducted with the pharmacists alongside the use of structured questionnaires to assess their involvement in drug education and experience with the clarity of physician prescription forms. A structured questionnaire was used to investigate patients’ and students’ PI reading habits. Drug PIs were collected from pharmacies, and their components were examined based on the World Health Organization’s (WHO) criteria for labeling pharmaceutical products.
Setting: The study was conducted at four selected hospital pharmacies, four community pharmacies, and the University of Cape Coast, in the Cape Coast Metropolis, Ghana.
Participants: The study included pharmacists working at the pharmacies, patients, and students of the University of Cape Coast, who visited any of these pharmacies.
Results: Fifty-three percent of pharmacists educate their patients on drug dosage, storage, and precautions during each patient visit, 17.6% hardly do, and 29.4% do not educate their patients. A majority of the sampled prescription forms submitted by patients to the pharmacists had illegible handwriting (63.7%) and unconventional prescription notations (78.0%). Of the 138 visiting patients, only a few (41.0%) read the PIs before drug use as compared to students (72.9%). Out of the 88 PIs collected, 90.2% had component deficiencies.
Conclusion: Pharmacists’ drug education to visiting patients was poor, just as patients’ PI reading habits. Most PIs had component deficiencies, and the majority of prescription forms had some medication error-provoking features. Going forward, pharmacists, physicians, drug manufacturers, and patients must perform their responsibilities toward the collective effort of minimizing medication errors associated with drug use.
研究目的本研究评估了以下用药错误指标:药剂师的用药教育、医生处方单的清晰度、患者和学生的药品包装说明书(PI)阅读习惯以及药品 PI 信息的充分性。 研究设计进行了一项横断面研究。对药剂师进行了一对一访谈,并使用结构化问卷评估他们参与药物教育的情况以及对医生处方单清晰度的体验。结构化问卷用于调查患者和学生阅读 PI 的习惯。从药房收集了药品 PI,并根据世界卫生组织(WHO)的药品标签标准对其组成部分进行了检查。 研究地点研究在加纳海岸角大都会的四家选定医院药房、四家社区药房和海岸角大学进行。 参与者:研究对象包括在这些药房工作的药剂师、患者以及访问这些药房的海岸角大学学生。 研究结果53%的药剂师在每次就诊时都会向患者讲解药物剂量、储存和注意事项,17.6%的药剂师几乎不向患者讲解,29.4%的药剂师不向患者讲解。在患者向药剂师提交的抽样处方单中,大部分存在字迹不清(63.7%)和处方记号不规范(78.0%)的问题。在 138 名就诊患者中,与学生(72.9%)相比,只有少数患者(41.0%)在用药前阅读了 PI。在收集到的 88 份 PI 中,90.2% 存在成分缺陷。 结论药剂师对就诊患者的药物教育和患者阅读 PI 的习惯都很差。大多数 PI 都存在内容缺陷,大多数处方单都有一些容易引起用药错误的特征。展望未来,药剂师、医生、药品生产商和患者必须履行各自的职责,共同努力将与用药相关的用药错误降至最低。
期刊介绍:
The Journal of Clinical Pharmacy and Therapeutics provides a forum for clinicians, pharmacists and pharmacologists to explore and report on issues of common interest. Reports and commentaries on current issues in medical and pharmaceutical practice are encouraged. Papers on evidence-based clinical practice and multidisciplinary collaborative work are particularly welcome. Regular sections in the journal include: editorials, commentaries, reviews (including systematic overviews and meta-analyses), original research and reports, and book reviews. Its scope embraces all aspects of clinical drug development and therapeutics, including:
Rational therapeutics
Evidence-based practice
Safety, cost-effectiveness and clinical efficacy of drugs
Drug interactions
Clinical impact of drug formulations
Pharmacogenetics
Personalised, stratified and translational medicine
Clinical pharmacokinetics.